Range
43.37 - 44.75
Vol / Avg.
438K/573.9K
Div / Yield
-
52 Wk
37.12 - 70.82
Mkt Cap
3.1B
Payout Ratio
-
Open
44.55
P/E
-
EPS
-1.05
Shares
70.5M
Outstanding
70.5M
Total Float
49.2M
Benzinga - May 26, 2021, 8:06AM
Benzinga - May 4, 2021, 4:27PM
Benzinga - Apr 14, 2021, 8:05AM
Benzinga - Apr 7, 2021, 8:51AM
Benzinga - Apr 1, 2021, 8:02AM
Benzinga - Mar 29, 2021, 7:27AM
Benzinga - Mar 15, 2021, 8:05AM
Benzinga - Mar 9, 2021, 8:10AM
Benzinga - Mar 4, 2021, 2:51PM
Benzinga - Feb 26, 2021, 6:47AM
Benzinga - Feb 25, 2021, 4:36PM
Benzinga - Feb 24, 2021, 5:16PM
Benzinga - Feb 17, 2021, 8:02AM
load more
Sector: Health Care.Industry: Biotechnology
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-04
REV
Q1 2021Est.ActualSurprise
EPS-1.510-1.830 -0.3200
REV98.800M117.942M19.142M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
PTCTPTC Therapeutics0%3.1B

PTC Therapeutics Frequently Asked Questions

Q

How do I buy PTC Therapeutics (PTCT) stock?

A

You can purchase shares of PTC Therapeutics (NASDAQ: PTCT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are PTC Therapeutics's (PTCT) competitors?

A

Other companies in PTC Therapeutics’s space includes: Burning Rock Biotech (NASDAQ:BNR), Karuna Therapeutics (NASDAQ:KRTX), Sage Therapeutics (NASDAQ:SAGE), FibroGen (NASDAQ:FGEN) and OPKO Health (NASDAQ:OPK).

Q

What is the target price for PTC Therapeutics (PTCT) stock?

A

The latest price target for PTC Therapeutics (NASDAQ: PTCT) was reported by RBC Capital on March 29, 2021. The analyst firm set a price target for 47.00 expecting PTCT to rise to within 12 months (a possible 7.70% upside). 10 analyst firms have reported ratings in the last year.

Q

Current Stock Price for PTC Therapeutics (PTCT)?

A

The stock price for PTC Therapeutics (NASDAQ: PTCT) is $43.64 last updated Today at 8:00:03 PM.

Q

Does PTC Therapeutics (PTCT) pay a dividend?

A

There are no upcoming dividends for PTC Therapeutics.

Q

When is PTC Therapeutics (NASDAQ:PTCT) reporting earnings?

A
PTC Therapeutics’s Q2 earnings are confirmed for after-market on August 4, 2021.
Q

Is PTC Therapeutics (PTCT) going to split?

A

There is no upcoming split for PTC Therapeutics.

Q

What sector and industry does PTC Therapeutics (PTCT) operate in?

A

PTC Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.